ABSTRACT
Photorefractive keratectomy (PRK) has been demonstrated to be a safe and effective treatment of low to moderate myopia (1,2). Since the introduction and advancement of the excimer laser, increasingly excellent results are being achieved with PRK. Despite these excellent results, postoperative pain, a relatively long recovery period, and the development of stromal haze limit the role of PRK in the current refractive surgery arena (3).
